Detalles de la búsqueda
1.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med
; 379(23): 2220-2229, 2018 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280641
2.
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial.
Lancet Oncol
; 20(12): 1702-1709, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628016
3.
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Lancet Oncol
; 19(11): 1468-1479, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262187
4.
Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer.
Anticancer Drugs
; 26(10): 1061-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26295868
5.
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Lancet Oncol
; 15(2): 143-55, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24411639
6.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(1): 59-68, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331154
7.
Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.
Pneumonol Alergol Pol
; 82(5): 437-44, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25133812
8.
Analysis of treatment results in primary germ cell tumours with mediastinal location: own experience.
Pneumonol Alergol Pol
; 82(2): 116-24, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24615195
9.
[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations]. / Rola systemowych metod leczenia u chorych na niedrobnokomórkowego raka pluca i zlosliwego miedzybloniaka oplucnej: uaktualnione zalecenia ekspertów.
Pneumonol Alergol Pol
; 82(2): 133-49, 2014.
Artículo
en Polaco
| MEDLINE | ID: mdl-24615197
10.
Clinicopathological characteristics of patients with primary tracheal tumors: Analysis of eighty-nine cases.
Thorac Cancer
; 15(11): 878-883, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429910
11.
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.
Front Oncol
; 14: 1341084, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322415
12.
Prognostic value of synaptophysin and chromogranin a expression in patients receiving palliative chemotherapy for advanced non-small-cell lung cancer.
Respiration
; 85(4): 289-96, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-22472871
13.
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Lancet Oncol
; 13(3): 292-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22336221
14.
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.
Lancet Oncol
; 13(1): 33-42, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22056021
15.
Savolitinib for non-small cell lung cancer.
Drugs Today (Barc)
; 59(1): 17-36, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811415
16.
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer.
Curr Oncol
; 30(2): 2049-2060, 2023 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826120
17.
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice.
J Clin Med
; 12(6)2023 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36983409
18.
Treatment Patterns, Testing Practices, and Outcomes in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer in Poland: A Descriptive Analysis of National, Multicenter, Real-World Data from the REFLECT Study.
Cancers (Basel)
; 15(5)2023 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900371
19.
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.
Cancers (Basel)
; 15(4)2023 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831618
20.
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Lung Cancer
; 186: 107418, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931445